As of 2025-11-06, the Relative Valuation of G1 Therapeutics Inc (GTHX) is (12.96) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.15 USD, the upside of G1 Therapeutics Inc based on Relative Valuation is -281.3%.
The range of the Relative Valuation is (12.98) - (12.96) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.3x - 15.3x | 15.3x |
| Forward P/E multiples | 15.2x - 15.3x | 15.2x |
| Fair Price | (12.98) - (12.96) | (12.96) |
| Upside | -281.6% - -281.3% | -281.3% |
| Date | P/E |